DeckTherapeutics announces the formation of Scientific Advisory Board
DeckTherapeutics today announced the formation of a Scientific Advisory Board comprised of some of the world’s foremost clinician scientists, practitioners and clinical trial experts, in the area of treating hypoxic-ischemic brain injuries.
DeckTherapeutics participates in Biotech Showcase
Reach out to discuss investing or partnering during the conference January 11-13, 2021. The annual partnering and investor conference Biotech Showcase is fully virtual in 2021 but the team at DeckTherapeutics is looking forward to meeting remotely with life science investors